![Luke Power](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luke Power
Direttore Finanziario/CFO presso
CARIS LIFE SCIENCES, INC.
Patrimonio netto: 3 M $ in data 30/06/2026
Profilo
Mr. Luke Power is a Chief Financial & Accounting Officer, Senior VP at Caris Life Sciences, Inc. Mr. Power was previously employed as a Manager by PricewaterhouseCoopers LLP.
He received his undergraduate degree from Waterford Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/05/2026 | 153.771 ( 0,05% ) | 3 M $ | 30/06/2026 |
Posizioni attive di Luke Power
| Società | Posizione | Inizio |
|---|---|---|
| CARIS LIFE SCIENCES, INC. | Direttore Finanziario/CFO | 01/02/2023 |
Precedenti posizioni note di Luke Power
| Società | Posizione | Fine |
|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 01/10/2011 |
Formazione di Luke Power
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
99
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Waterford Institute of Technology
 Waterford Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
